Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice

Clinical and Experimental Immunology

Volumn 171, Issue 3, 2013, Pages 263-272

  Karner J ^a   Meager, A ^b   Laan, M ^a   Maslovskaja, J ^a   Pihlap, M ^a   Remm, A ^a   Juronen, E ^a   Wolff, A S B ^c   Husebye, E S ^c   Podkrajsek K T ^d   Bratanic, N ^d   Battelino, T ^d   Willcox, N ^e   Peterson, P ^a   Kisand, K ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

AIRE; APECED; IgG4; IL 22; Thymoma; Type I interferons

Indexed keywords

ALPHA2A INTERFERON; CYTOKINE ANTIBODY; EPITOPE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TH17 CELL;

ANIMALS; AUTOANTIBODIES; CYTOKINES; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; INTERFERON-ALPHA; INTERLEUKIN-17; INTERLEUKINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYENDOCRINOPATHIES, AUTOIMMUNE; TRANSCRIPTION FACTORS;

EID: 84873317650     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12024     Document Type: Article

References (49)

1. Peterson P, Org T, Rebane A. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol 2008; 8:948-957.
2. Mathis D, Benoist C. Aire. Annu Rev Immunol 2009; 27:287-312.
3. Nagamine K, Peterson P, Scott HS etal. Positional cloning of the APECED gene. Nat Genet 1997; 17:393-398.
4. Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997; 17:399-403.
5. Husebye ES, Perheentupa J, Rautemaa R etal. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 2009; 265:514-529.
6. Kisand K, Lilic D, Casanova JL etal. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. Eur J Immunol 2011; 41:1517-1527.
7. Ramsey C, Winqvist O, Puhakka L etal. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002; 11:397-409.
8. Kuroda N, Mitani T, Takeda N etal. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol 2005; 174:1862-1870.
9. Jiang W, Anderson MS, Bronson R etal. Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med 2005; 202:805-815.
10. Pontynen N, Miettinen A, Arstila TP etal. Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients. J Autoimmun 2006; 27:96-104.
11. Kekalainen E, Miettinen A, Arstila TP. Does the deficiency of Aire in mice really resemble human APECED? Nat Rev Immunol 2007; 7:1.
12. Hubert FX, Kinkel SA, Crewther PE etal. Aire-deficient C57BL/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype. J Immunol 2009; 182:3902-3918.
13. Meager A, Visvalingam K, Peterson P etal. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006; 3:e289.
14. Toth B, Wolff AS, Halasz Z etal. Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy. Clin Endocrinol (Oxf) 2010; 72:641-647.
15. Meloni A, Furcas M, Cetani F etal. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2008; 93:4389-4397.
16. Kisand K, Link M, Wolff AS etal. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood 2008; 112:2657-2666.
17. Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome. Ann NY Acad Sci 2011; 1246:77-91.
18. Meager A, Vincent A, Newsom-Davis J etal. Spontaneous neutralising antibodies to interferon - alpha and interleukin-12 in thymoma-associated autoimmune disease. Lancet 1997; 350:1596-1597.
19. Kisand K, Boe Wolff AS, Podkrajsek KT etal. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010; 207:299-308.
20. Burbelo PD, Browne SK, Sampaio EP etal. Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood 2010; 116:4848-4858.
21. Holbro A, Jauch A, Lardinois D etal. High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol 2012; 73:287-290.
22. Puel A, Doffinger R, Natividad A etal. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010; 207:291-297.
23. Oftedal BE, Kampe O, Meager A etal. Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyendocrine syndrome type I by radioligand binding assay using fusion proteins. Scand J Immunol 2011; 74:327-333.
24. Wolk K, Witte E, Witte K etal. Biology of interleukin-22. Semin Immunopathol 2010; 32:17-31.
25. Puel A, Picard C, Cypowyj S etal. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr Opin Immunol 2010; 22:467-474.
26. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202:8-32.
27. Cho JS, Pietras EM, Garcia NC etal. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010; 120:1762-1773.
28. Conti HR, Gaffen SL. Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect 2010; 12:518-527.
29. Wolff AS, Erichsen MM, Meager A etal. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 2007; 92:595-603.
30. Burbelo PD, Ching KH, Klimavicz CM etal. Antibody profiling by luciferase immunoprecipitation systems (LIPS). J Vis Exp 2009; 32:e1549. doi:10.3791/1549.
31. Hassler S, Ramsey C, Karlsson MC etal. Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma. Blood 2006; 108:1941-1948.
32. Teesalu K, Agardh D, Panarina M etal. A modified ELISA for improved detection of IgA, IgG, and IgM anti-tissue transglutaminase antibodies in celiac disease. Clin Chim Acta 2009; 403:37-41.
33. Dieterich W, Ehnis T, Bauer M etal. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3:797-801.
34. Kisand KE, Kisand KV, Karvonen AL etal. Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology. APMIS 1998; 106:884-892.
35. Brozzetti A, Marzotti S, La Torre D etal. Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response. Eur J Endocrinol 2010; 163:309-317.
36. Boe AS, Bredholt G, Knappskog PM etal. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. Eur J Endocrinol 2004; 150:49-56.
37. Aalberse R. The role of IgG antibodies in allergy and immunotherapy. Allergy 2011; 66 (Suppl. 95):28-30.
38. van der Neut Kolfschoten M, Schuurman J, Losen M etal. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317:1554-1557.
39. Mobs C, Slotosch C, Loffler H etal. Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy. Int Arch Allergy Immunol 2008; 147:171-178.
40. Muller UR. Bee venom allergy in beekeepers and their family members. Curr Opin Allergy Clin Immunol 2005; 5:343-347.
41. Aoki V, Sousa JX, Jr, Diaz LA. Pathogenesis of endemic pemphigus foliaceus. Dermatol Clin 2011; 29:413-418, viii.
42. Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol 2011; 23:114-118.
43. Wang X, Laan M, Bichele R etal. Post-Aire maturation of thymic medullary epithelial cells involves selective expression of keratinocyte-specific autoantigens. Front Immun 2012; 3:19. doi:10.3389/fimmu.2012.00019.
44. Vincent AC, McConville J, Newsom-Davis J. Is 'seronegative' MG explained by autoantibodies to MuSK? Neurology 2005; 64:399.
45. Grant GA. Synthetic peptides for production of antibodies that recognize intact proteins. Curr Protoc Protein Sci 2002; 18.3.1-18.3.19.
46. Quadt-Akabayov SR, Chill JH, Levy R etal. Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex. Protein Sci 2006; 15:2656-2668.
47. Bleicher L, de Moura PR, Watanabe L etal. Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett 2008; 582:2985-2992.
48. Meloni A, Willcox N, Meager A etal. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 2012; 97:1114-1124.
49. Ahlgren KM, Moretti S, Lundgren BA etal. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model. Eur J Immunol 2011; 41:235-245.